Celgene Surprises With Melanoma Drug Study Victory

by Web Master, Benzinga Editor
October 2, 2012 8:29 AM | 3 seconds read |
Celgene's Abraxane delays tumor growth in patients with advanced melanoma.
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Comments
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!